Osteoarthritis and its origins: Disease development at the cellular and molecular level - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

Osteoarthritis and its origins: Disease development at the cellular and molecular level


Clinical Edge


31. Amin, A.R. et al.: Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: Influence of nitric oxide. J. Clin. Invest. 99:1231-1237; 1997.

32. Lubberts, E. et al.: Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. Arthritis Rheum 43:1300-1306; 2000.

33. Laufer, S.: Role of eicosanoids in structural degradation in osteoarthritis. Curr. Opin. Rheumatol. 15:623-627; 2003.

34. Amin, A.R. et al.: Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. J. Clin. Invest. 99:1231-1237; 1997.

35. Cleland, L.G. et al.; Omega-6/omega-3 fatty acids and arthritis. World Rev. Nutr. Diet 92:152-168; 2003.

36. Trumble, T.N. et al.: Correlation of prosaglandin E2 concentrations in synovial fluid with ground reaction forces and clinical variables for pain or inflammation in dogs with osteoarthritis induced by transection of the cranial cruciate ligament. AJVR 65:1269-1275; 2004.

37. Bukata, S.V. et al.: PGE2 and IL-6 production by fibroblasts in response to titanium wear debris particles is mediated through a COX-2 dependent pathway. J. Orthop. Res. 22:6-12; 2003.

38. Tipton, D.A. et al.: Cyclooxygenase-2 inhibitors decrease interleukin-1 beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts. J. Periodontol. 74:1754-1763; 2004.

39. Hansen, R.A. et al.: Long chain n-3 PUFA improve biochemical parameters associated with canine osteoarthritis. Proc. Am. Oil Chem. Soc., Cincinnati, May 9-12, 2004.


ADVERTISEMENT

Source: Clinical Edge,
Click here